RNS Number : 3116Z
Vianet Group PLC
10 January 2024

10 January 2024

Vianet Group PLC

(the "Company")

Share Buyback and Total Voting Rights

Further to the Company's announcement made on 9 November 2023, the Company announces that, on 10 January 2024, it purchased 50,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares").

The purchased Ordinary Shares will be cancelled.

Date of purchase:

10 January 2024

Aggregate number of ordinary shares purchased:

50,000

Lowest price paid per share (pence per share):

87.5

Highest price paid per share (pence per share):

87.5

Volume weighted average price paid per share (pence per share):

87.5

Total Voting Rights

Following the purchase and cancellation of these Ordinary Shares, the Company's issued share capital will consist of 29,403,414 Ordinary Shares with each Ordinary Share carrying the right to one vote. There are no Ordinary Shares held in treasury and therefore, the total number of voting rights in the Company following Admission will be 29,403,414. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a detailed breakdown of individual trades is available below:

No. of Ordinary Shares Purchased

Transaction price (Pence)

Time of transaction

Trading Venue

50,000

87.5

13.25

London Stock Exchange

(AIM)

Enquiries:

Vianet Group plc


James Dickson, Chairman & CEO

Mark Foster, CFO

Tel: +44 (0) 1642 358 800

www.vianetplc.com

Cavendish Capital Markets Limited


Camilla Hume/Stephen Keys

Tel: +44 (0) 20 7220 0500


www.cavendish.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSSFWFASELSESF